River Blindness MERCK AND RIVER BLINDNESS Does Dr. Roy Vagelos or Merck and Co. have a responsibility to pursue R&D for a human version of Ivermectin‚ the drug for river blindness? Lets take this question to a positive evaluation. Developing a drug to combat river blindness has potential costs and benefits. Merck discovered an opportunity to treat millions of infected people around the world but knew that the drug would probably never see commercial use. Investing millions
Premium Pharmacology Medicine Pharmaceutical drug
Merck and Co.‚ River Blindness Ethical Case Analysis Lennard de Jong Excelsior College Author Note This paper was prepared for Business Ethics‚ Ethical Case Analysis‚ taught by Dr. Moser. Introduction and Situational Analysis The ethical dilemma in Merck and River Blindness is whether to pursue research that may or may result in profit‚ or to choose the safe option and go for profit rather than researching the drug. The drug could possibly lead to curing the deadly and detrimental disease
Premium Ethics Morality
CASE 5.1: MERCK ACQUISITION OF MEDCO Abstract Corporate mergers and acquisitions (M&A) have become popular across the globe during the last two decades due to globalization‚ liberalization‚ technological developments‚ and competitive business environment (Fisher & Siburg‚ 2009). The synergistic gains from M&A may result from efficient management‚ economies of scale‚ profitable use of assets‚ exploitation of market power‚ and the use of complementary resources (Mitchell
Premium Pharmacology Pharmaceutical industry Pharmacy
grocery and fresh meat are also substitutes of supermarket’s products. Bargaining Power of buyers. Buyers are the people/ organizations who create demand in an industry. Buyers can be divided into two types in supermarket industry- price sensitive(larger Ed) and non-price sensitive( Smaller Ed). Price sensitive people are those housewives and non-price sensitive people are those white-collar. Generally‚ the bargaining power of buyers is weak but that of non-price sensitive one is even weaker.
Premium Supermarket Retailing Milk
negotiation that I was pleased by was my preparation. This was a very complicated negotiation so the preparation for it was very critical. I really didn’t have many options available to me. I felt going in to the negotiation that I would have very minimal power so my BATNA was to declare bankruptcy. I felt that this was the only card that I could play‚ I knew that Pat would be worried that if I went into bankruptcy he would lose some of the 200k loan that I owed him. My biggest concern going in was that I
Premium Collective bargaining Negotiation Best alternative to a negotiated agreement
Merck & Co.‚ Inc. Case If one hold a key to resolve a very serious problem‚ one has a responsibility to put an effort to make it happen‚ at least try one’s best. In this case‚ river blindness disease was a very serious problem‚ and Dr. Vagelos was the one who could make a decision as to whether the research and development of a human version of ivermectin should be carried on‚ then it was his responsibility to pursue it. Caused by a parasitic worm carried by a tiny black fly‚ the disease
Premium Blindness Human Onchocerciasis
Pharmaceutical Industry The pharmaceutical industry includes companies that research‚ develop‚ market or distribute generic and branded drugs. The industry expanded during the 1980’s and drugs to treat heart disease and AIDS were prominent. Consumer demand for nutritional supplements and alternative medicine increased during the 1990’s with the Internet facilitating direct purchases of drugs. Advertising for direct consumption of pharmaceutical drugs became more prominent; pharmaceutical companies
Premium Inventory Pharmaceutical industry Dividend yield
Jim Mesplie MBA 519 – Competitive Strategy Case Analysis #4 FACTS Beginning as a small scale manufacturer of chemical in the United States‚ Merck Research Labs (MRL) became the top notch research institution in the pharmaceutical industry by World War II. By attracting the top talent in chemistry‚ biology‚ and pharmacology‚ MRL emerged as the leader in human pharmaceuticals with the release of highly necessary drugs to treat infections‚ and tuberculosis. MRL focused their strengths on three
Premium Generic drug Pharmacology Pharmaceutical industry
MAN 4720 Nov. 15‚ 2011 Merck‚ the FDA‚ and the Vioxx Recall In 1999 the Food and Drug Administration (FDA) had approved Vioxx‚ what would become Merck’s “blockbuster” drug. Although the FDA had approved the drug there was uncertainty of the safety of drug. Vioxx was approved to treat a variety of conditions‚ such as osteoarthritis and acute pain‚ but there was also a chance that it would increase cardiovascular problems. What I found most interesting about this case was the changes in how drugs
Premium Pharmacology Advertising Clinical trial
Merck‚ the FDA‚ and the VIOXX Recall MBA 520 Ethics and Leadership in a Global Environment 11.15.2009 MBA 520 15 November 2009 Merck‚ the FDA‚ and the VIOXX Recall In 1999‚ Merck started a clinical trial called VIGOR‚ checking the effectiveness of VIOXX in patients with gastrointestinal problems‚ and in this trial they noted for the first time that patients taking VIOXX suffered roughly twice as many heart attacks and strokes as those taking the control‚ Naproxen.
Premium Social responsibility Clinical trial Corporate social responsibility